ÂÜÀòÂÒÂ×

Charlie Aprahamian is a Healthcare Investor at NewSpring since June 2022, where the firm focuses on partnering with high-performing companies in the lower-middle market. Prior to this position, Charlie served as a Private Equity Summer Analyst at UR Student Managed Investment Fund and held roles including Value Fund Manager at Blue Heron Capital and Growth Equity Intern at PACE Equity, LLC. Charlie began a career in finance as a Market Research Intern at Monument Consulting. Academic credentials include a Bachelor of Science in Business Administration, with a major in Economics and a concentration in Finance, from the University of Richmond, along with a foundational education from Trinity Episcopal School.